Titre : Comptes-rendus de sortie des patients

Comptes-rendus de sortie des patients : Questions médicales fréquentes

Termes MeSH sélectionnés :

Policy Making
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Comptes-rendus de sortie des patients : Questions médicales les plus fréquentes", "headline": "Comptes-rendus de sortie des patients : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Comptes-rendus de sortie des patients : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-11", "dateModified": "2025-04-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Comptes-rendus de sortie des patients" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dossiers médicaux", "url": "https://questionsmedicales.fr/mesh/D008499", "about": { "@type": "MedicalCondition", "name": "Dossiers médicaux", "code": { "@type": "MedicalCode", "code": "D008499", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.308.940.968" } } }, "about": { "@type": "MedicalCondition", "name": "Comptes-rendus de sortie des patients", "alternateName": "Patient Discharge Summaries", "code": { "@type": "MedicalCode", "code": "D063886", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Christine Maria Schwarz", "url": "https://questionsmedicales.fr/author/Christine%20Maria%20Schwarz", "affiliation": { "@type": "Organization", "name": "Research Unit for Safety and Sustainability in Healthcare, c/o, Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery , Medical University of Graz, Graz, Austria." } }, { "@type": "Person", "name": "Magdalena Hoffmann", "url": "https://questionsmedicales.fr/author/Magdalena%20Hoffmann", "affiliation": { "@type": "Organization", "name": "Research Unit for Safety and Sustainability in Healthcare, c/o, Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery , Medical University of Graz, Graz, Austria. magdalena.hoffmann@medunigraz.at." } }, { "@type": "Person", "name": "Gerald Sendlhofer", "url": "https://questionsmedicales.fr/author/Gerald%20Sendlhofer", "affiliation": { "@type": "Organization", "name": "Research Unit for Safety and Sustainability in Healthcare, c/o, Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery , Medical University of Graz, Graz, Austria." } }, { "@type": "Person", "name": "Thomas R Campion", "url": "https://questionsmedicales.fr/author/Thomas%20R%20Campion", "affiliation": { "@type": "Organization", "name": "Department of Population Health, Weill Cornell Medicine, New York, NY 10065, United States." } }, { "@type": "Person", "name": "Rebecca Brundin-Mather", "url": "https://questionsmedicales.fr/author/Rebecca%20Brundin-Mather", "affiliation": { "@type": "Organization", "name": "Department of Critical Care Medicine, University of Calgary, Calgary T2N 4Z6, Alberta, Canada." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Applying behaviour change models to policy-making: development and validation of the Policymakers' Information Use Questionnaire (POLIQ).", "datePublished": "2023-01-23", "url": "https://questionsmedicales.fr/article/36691025", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12961-022-00942-y" } }, { "@type": "ScholarlyArticle", "name": "Research can be integrated into public health policy-making: global lessons for and from Spanish economic evaluations.", "datePublished": "2022-06-18", "url": "https://questionsmedicales.fr/article/35717247", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12961-022-00875-6" } }, { "@type": "ScholarlyArticle", "name": "Strengthening Governance and Institutional Capacity at the Nutrition-Food Supply Policy Nexus Comment on \"What Opportunities Exist for Making the Food Supply Nutrition Friendly? A Policy Space Analysis in Mexico\".", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/35964160", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.34172/ijhpm.2022.7325" } }, { "@type": "ScholarlyArticle", "name": "Food system policy making and innovation at the local level: Exploring the response of Australian local governments to critical food systems issues.", "datePublished": "2022-06-19", "url": "https://questionsmedicales.fr/article/35718947", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/hpja.626" } }, { "@type": "ScholarlyArticle", "name": "Understanding accelerators to improve SDG-related outcomes for adolescents-An investigation into the nature and quantum of additive effects of protective factors to guide policy making.", "datePublished": "2023-01-06", "url": "https://questionsmedicales.fr/article/36607964", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0278020" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Méthodes épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D004812" }, { "@type": "ListItem", "position": 5, "name": "Collecte de données", "item": "https://questionsmedicales.fr/mesh/D003625" }, { "@type": "ListItem", "position": 6, "name": "Documents", "item": "https://questionsmedicales.fr/mesh/D011996" }, { "@type": "ListItem", "position": 7, "name": "Dossiers médicaux", "item": "https://questionsmedicales.fr/mesh/D008499" }, { "@type": "ListItem", "position": 8, "name": "Comptes-rendus de sortie des patients", "item": "https://questionsmedicales.fr/mesh/D063886" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Comptes-rendus de sortie des patients - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Comptes-rendus de sortie des patients", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Comptes-rendus de sortie des patients", "description": "Quels diagnostics sont souvent notés dans un compte-rendu ?\nComment le diagnostic est-il confirmé dans le rapport ?\nQuelle est l'importance du diagnostic dans le compte-rendu ?\nLes diagnostics sont-ils classés dans le compte-rendu ?\nComment les diagnostics influencent-ils le traitement ?", "url": "https://questionsmedicales.fr/mesh/D063886?mesh_terms=Policy+Making&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Comptes-rendus de sortie des patients", "description": "Quels symptômes sont souvent mentionnés ?\nComment les symptômes sont-ils évalués ?\nLes symptômes changent-ils après le traitement ?\nLes symptômes sont-ils classés par gravité ?\nComment les symptômes influencent-ils le suivi ?", "url": "https://questionsmedicales.fr/mesh/D063886?mesh_terms=Policy+Making&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Comptes-rendus de sortie des patients", "description": "Quelles mesures préventives sont recommandées ?\nComment la prévention est-elle abordée dans le rapport ?\nLa prévention est-elle personnalisée ?\nQuels conseils de prévention sont souvent inclus ?\nLa prévention est-elle suivie après la sortie ?", "url": "https://questionsmedicales.fr/mesh/D063886?mesh_terms=Policy+Making&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Comptes-rendus de sortie des patients", "description": "Quels types de traitements sont documentés ?\nComment les traitements sont-ils justifiés ?\nLes traitements sont-ils suivis d'effets secondaires ?\nComment les traitements sont-ils planifiés ?\nLes traitements sont-ils adaptés après la sortie ?", "url": "https://questionsmedicales.fr/mesh/D063886?mesh_terms=Policy+Making&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Comptes-rendus de sortie des patients", "description": "Quelles complications peuvent survenir après la sortie ?\nComment les complications sont-elles signalées ?\nLes complications sont-elles documentées dans le rapport ?\nComment prévenir les complications après la sortie ?\nLes complications influencent-elles le suivi ?", "url": "https://questionsmedicales.fr/mesh/D063886?mesh_terms=Policy+Making&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Comptes-rendus de sortie des patients", "description": "Quels facteurs de risque sont souvent identifiés ?\nComment les facteurs de risque sont-ils évalués ?\nLes facteurs de risque influencent-ils le traitement ?\nLes facteurs de risque sont-ils notés dans le compte-rendu ?\nComment réduire les facteurs de risque après la sortie ?", "url": "https://questionsmedicales.fr/mesh/D063886?mesh_terms=Policy+Making&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Quels diagnostics sont souvent notés dans un compte-rendu ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les diagnostics incluent des maladies aiguës, chroniques et des complications post-opératoires." } }, { "@type": "Question", "name": "Comment le diagnostic est-il confirmé dans le rapport ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic est confirmé par des examens cliniques, des tests de laboratoire et des imageries." } }, { "@type": "Question", "name": "Quelle est l'importance du diagnostic dans le compte-rendu ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Il guide le suivi médical et les traitements à administrer après la sortie." } }, { "@type": "Question", "name": "Les diagnostics sont-ils classés dans le compte-rendu ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent classés par ordre de gravité ou de chronologie." } }, { "@type": "Question", "name": "Comment les diagnostics influencent-ils le traitement ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils déterminent les protocoles de traitement et les médicaments prescrits." } }, { "@type": "Question", "name": "Quels symptômes sont souvent mentionnés ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, fièvre, fatigue et autres signes cliniques pertinents." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils évalués ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont évalués par l'examen physique et les antécédents médicaux du patient." } }, { "@type": "Question", "name": "Les symptômes changent-ils après le traitement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le compte-rendu note souvent l'évolution des symptômes post-traitement." } }, { "@type": "Question", "name": "Les symptômes sont-ils classés par gravité ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être classés en fonction de leur impact sur la santé du patient." } }, { "@type": "Question", "name": "Comment les symptômes influencent-ils le suivi ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils orientent les recommandations de suivi et les consultations nécessaires." } }, { "@type": "Question", "name": "Quelles mesures préventives sont recommandées ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les mesures incluent vaccinations, conseils diététiques et exercices physiques." } }, { "@type": "Question", "name": "Comment la prévention est-elle abordée dans le rapport ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elle est abordée par des recommandations spécifiques basées sur le diagnostic." } }, { "@type": "Question", "name": "La prévention est-elle personnalisée ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent adaptée aux antécédents médicaux et au mode de vie du patient." } }, { "@type": "Question", "name": "Quels conseils de prévention sont souvent inclus ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des conseils sur l'alimentation, l'exercice et l'arrêt du tabac sont fréquents." } }, { "@type": "Question", "name": "La prévention est-elle suivie après la sortie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le suivi des mesures préventives est souvent recommandé lors des consultations." } }, { "@type": "Question", "name": "Quels types de traitements sont documentés ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent médications, interventions chirurgicales et thérapies physiques." } }, { "@type": "Question", "name": "Comment les traitements sont-ils justifiés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont justifiés par les diagnostics et l'évolution des symptômes du patient." } }, { "@type": "Question", "name": "Les traitements sont-ils suivis d'effets secondaires ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les effets secondaires potentiels sont souvent notés pour chaque traitement." } }, { "@type": "Question", "name": "Comment les traitements sont-ils planifiés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont planifiés en fonction des besoins individuels et des protocoles médicaux." } }, { "@type": "Question", "name": "Les traitements sont-ils adaptés après la sortie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des ajustements peuvent être nécessaires en fonction de l'évolution du patient." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après la sortie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent infections, douleurs persistantes et complications liées aux traitements." } }, { "@type": "Question", "name": "Comment les complications sont-elles signalées ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont signalées par des observations cliniques et des tests de suivi." } }, { "@type": "Question", "name": "Les complications sont-elles documentées dans le rapport ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent documentées pour informer le suivi médical." } }, { "@type": "Question", "name": "Comment prévenir les complications après la sortie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par des soins appropriés et le respect des recommandations médicales." } }, { "@type": "Question", "name": "Les complications influencent-elles le suivi ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent nécessiter des consultations supplémentaires et des ajustements de traitement." } }, { "@type": "Question", "name": "Quels facteurs de risque sont souvent identifiés ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les antécédents familiaux et les habitudes de vie." } }, { "@type": "Question", "name": "Comment les facteurs de risque sont-ils évalués ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont évalués par l'anamnèse et des tests de dépistage spécifiques." } }, { "@type": "Question", "name": "Les facteurs de risque influencent-ils le traitement ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent orienter les choix thérapeutiques et les recommandations de suivi." } }, { "@type": "Question", "name": "Les facteurs de risque sont-ils notés dans le compte-rendu ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent notés pour une meilleure gestion des soins futurs." } }, { "@type": "Question", "name": "Comment réduire les facteurs de risque après la sortie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "La réduction passe par des changements de mode de vie et un suivi médical régulier." } } ] } ] }

Sources (10000 au total)

Applying behaviour change models to policy-making: development and validation of the Policymakers' Information Use Questionnaire (POLIQ).

The purpose of this study was to develop and validate the Policymakers' Information Use Questionnaire (POLIQ) to capture the intention of individuals in decision-making positions, such as health polic... The development and validation comprised three steps: item generation, qualitative face validation with cognitive debriefing and factorial construct validation. Confirmatory factor analysis was applie... Cognitive debriefing allowed for small adjustments in language for clarity, including simultaneous validation of the English and French questionnaires. Participants found that the questions were clear... Measuring decision-makers' behaviour in relation to research evidence use is challenging. We provide initial evidence on face validity and appropriate measurement properties of the POLIQ based on a co...

Strengthening Governance and Institutional Capacity at the Nutrition-Food Supply Policy Nexus Comment on "What Opportunities Exist for Making the Food Supply Nutrition Friendly? A Policy Space Analysis in Mexico".

Cervantes et al have provided an insightful addition to the policy literature by identifying the contextual, political, and policy factors that create constraints and opportunities for putting nutriti...

Food system policy making and innovation at the local level: Exploring the response of Australian local governments to critical food systems issues.

Urgent action is required by all levels of government to create a food system capable of nourishing a rapidly growing population while remaining within planetary boundaries. This study investigated po... An online survey was completed by LGs (n = 64) in New South Wales and Victoria, Australia. Questions focused on LGs' food system-related policies and programs, barriers to and enablers of engaging in ... Preventing food waste, organising food-related social/cultural events and providing potable water were the most commonly reported activities. Few LGs reported policies/activities on market gardening o... Australian LGs undertake a wide range of actions addressing diverse food system issues; however, internal and external barriers constrain their involvement in creating a healthy, sustainable and equit...

Understanding accelerators to improve SDG-related outcomes for adolescents-An investigation into the nature and quantum of additive effects of protective factors to guide policy making.

Recent evidence has shown support for the United Nations Development Programme (UNDP) accelerator concept, which highlights the need to identify interventions or programmatic areas that can affect mul...

Embedding rapid reviews in health policy and systems decision-making: Impacts and lessons learned from four low- and middle-income countries.

Demand for rapid evidence-based syntheses to inform health policy and systems decision-making has increased worldwide, including in low- and middle-income countries (LMICs). To promote use of rapid sy... While the selected platforms had experience in health policy and systems research and evidence syntheses, platforms were less confident conducting rapid evidence syntheses. A technical assistance cent... Platforms provided rapid syntheses across a range of AHPSR themes, and successfully engaged national- and state-level policy-makers. Examples of substantial policy impact were observed, including for ... The ERA initiative successfully established rapid response platforms in four LMICs. The short timeframe limited the number of rapid products produced, but there were examples of substantial impact and...

Uncovering the Effect of European Policy-Making Initiatives in Addressing Nutrition-Related Issues: A Systematic Literature Review and Bibliometric Analysis on Front-of-Pack Labels.

The last decades have been marked by the introduction of front-of-pack labels (FoPL) as an institutional corrective action against obesity and nutrition-related illnesses. However, FoPL-related policy...

From Local Action to Global Policy: A Comparative Policy Content Analysis of National Policies to Address Musculoskeletal Health to Inform Global Policy Development.

Global policy to guide action on musculoskeletal (MSK) health is in a nascent phase. Lagging behind other non-communicable diseases (NCDs) there is currently little global policy to assist governments... Multi-modal search strategy incorporating a systematic online search targeted at the 30 most populated nations; a call to networked experts; a specified question in a related eDelphi questionnaire; an... The search yielded 165 documents with 41 retained after removal of duplicates and exclusions. Only three documents were comprehensive national strategies addressing MSK health. The most common conditi... There are few examples of national strategic policy to address MSK health; however, many countries are moving towards this by documenting the burden of disease and developing policies for MSK services...

Inclusion of people with disabilities in Chilean health policy: a policy analysis.

Around 18% of the population in Chile has disabilities. Evidence shows that this population has greater healthcare needs, yet they face barriers to accessing healthcare due to health system failures. ... A policy content analysis was conducted of 12 health policy documents using the EquiFrame framework, adapted to assess disability inclusion. Documents were reviewed and rated on their quality of commi... Core human rights concepts of disability were mentioned at least once in nearly all health policy documents (92%). However, 50% had poor policy commitments for disability. Across policies, Prevention ... Improvements are needed in both the development and implementation of disability-inclusive health policies in Chile, to support the achievement of the right to healthcare for people with disabilities ...

Understanding successful policy innovation: The case of Portuguese drug policy.

In 2000, the Portuguese minority socialist government decriminalized the possession and consumption of drugs. This law made Portugal unique in having a formal system that directs the person using drug... After discussing the limitations of the existing literature, we present a new theoretical framework: the 'six-stars' framework. We argue that successful policy innovation in democracies will only occu... The proposed 'six-stars' framework of successful drug policy innovation shows the importance of electoral mandates, communication, inclusion, transparency, deliberation and evaluation when designing i...